On This Page

Healthcare document processing company offering the Concord Connect platform for straight-through processing with cloud fax, AI automation, Direct Secure Messaging, and EHR integration.

Concord Technologies

4B+Pages of PHI processed annually (self-reported)
99.99%Network uptime (advertised)
99%Customer retention rate (self-reported)
30+Years operating in healthcare document exchange

Overview

Founded in 1996 and headquartered in Seattle, Washington, Concord Technologies spent its first two decades as a healthcare document exchange provider, processing fax, email, and SFTP traffic for providers and payers. The February 2025 launch of Concord Connect at the ViVE conference marked a deliberate repositioning: from point-solution document exchange toward end-to-end intelligent document processing covering intake, AI extraction, validation, and EHR delivery. The company self-reports processing 4 billion pages of protected health information (PHI) annually across infrastructure it describes as one of the largest healthcare-focused data centers in the world. Neither figure has been independently audited.

At HIMSS 2026 in March 2026, Concord extended that repositioning further by integrating Direct Secure Messaging (DSM) natively into Concord Connect, unifying digital fax and structured data transport into a single intake platform. The company also moderated a main-stage HIMSS panel on LLMs versus standards-based interoperability, a public signal that Concord is betting on AI-driven approaches over traditional HL7/FHIR compliance as the primary path to healthcare data exchange.

That repositioning is unfolding against a significant M&A backdrop. Ion Analytics reported in February 2026 that Concord appointed Baird as sell-side advisor following a competitive bakeoff, with EBITDA cited at USD 40-50M by anonymous sources. Excellere Partners (Denver) holds a minority stake acquired in 2019; founder Chris Moore retains a controlling interest. Concord, Baird, and Excellere did not respond to comment requests. All deal details are sourced from three anonymous parties and should be treated as credible but unverified.

Two bolt-on acquisitions in 2024 shaped the valuation pitch: Biscom (healthcare document exchange, acquired from ParkerGate and Eldridge Industries in January 2024) expanded the provider network, and Opero (Salesforce AppExchange developer, acquired November 2024) added a commercial application layer. Together they signal a consolidation strategy ahead of exit rather than organic product expansion.

No Gartner, KLAS, or IDC positioning has been cited in coverage since the 2024 IDC Digital Fax MarketScape Leader designation. The company reports a 99% customer retention rate and 84 Net Promoter Score, but no third-party validation of these figures appears in available sources.

How Concord Technologies processes documents

Concord Connect is the company's straight-through processing platform for healthcare. As of March 2026, the pipeline covers six stages: secure document receipt via Concord's exchange network (advertised 99.99% uptime), AI-driven classification and data extraction, configurable routing workflows, human-in-the-loop intervention triggered by AI confidence indicators, automated delivery into EHRs and systems of record, and now native Direct Secure Messaging transport for structured data.

The DSM integration is the most significant product change since the platform's launch. Before March 2026, Concord Connect handled unstructured documents arriving via fax, email, and SFTP. The addition of DSM means the platform now ingests both structured and unstructured patient data through a single interface, eliminating the separate intake pipelines that previously required manual handoffs between systems. CTO Chris Larkin described the rationale directly: "Concord's ability to intelligently receive and process both structured and unstructured data addresses one of healthcare's most persistent challenges: fragmented intake workflows. By integrating multiple modalities like Digital Fax and DSM into a single platform, and single user experience, we're enabling providers to triage and route patient information faster than ever before."

The platform is marketed under a "Practical AI" brand, a deliberate signal against capability-maximalist AI deployments, emphasizing swift return on investment and ease of deployment over frontier model performance. CEO William Cavanaugh framed the strategic intent at HIMSS: "By expanding the capabilities of Concord Connect, we are reimagining how patient information moves across healthcare so it can be accessed, understood, and acted on without delay."

The "last mile" EHR integration remains the platform's stated primary differentiator. The argument is that point solutions stop at extraction and leave integration work to the customer. No processing accuracy rates, time savings figures, pricing tiers, or named early-adopter organizations have been disclosed publicly. The absence of benchmark data is a notable gap for buyers evaluating the platform against specialized IDP vendors.

A distribution partnership announced at RSNA 2025 makes Concord Connect available to Konica Minolta Healthcare's Exa Platform users, a radiology-focused installed base that aligns with Concord's published content push on radiology automation in early 2026. Contractual scope and current customer count have not been disclosed.

Use cases

Patient document intake

Concord Connect automates the receipt, classification, and routing of patient forms, referrals, and medical records to clinical departments through configurable workflows. With DSM now integrated alongside digital fax, providers can consolidate all inbound patient data, whether structured or unstructured, into a single triage queue. Supported document types include prior authorizations, referrals, and clinical record exchange.

Insurance claims automation

Payer document processing for claims intake, policy verification, and automated data extraction integrates directly into claims management systems. Revenue cycle documentation is listed among supported workflows. See the healthcare claims automation guide for implementation context.

Straight-through processing for healthcare

End-to-end document automation from multi-channel intake through EHR delivery minimizes manual intervention and data entry. Concord repeats the "Straight-Through Processing for Healthcare" framing across its anniversary release, Concord Connect launch, and HIMSS 2026 presence as a deliberate category-creation move, positioning itself against both legacy fax-and-exchange vendors and general-purpose AI platforms. Whether the category claim holds depends on benchmark data and customer evidence that have not yet been made public.

Interoperability and LLM-driven data exchange

The HIMSS 2026 panel, titled "Rethinking Interoperability: Is It Time to Trust LLMs over Standards?", signals Concord's emerging position on AI as an alternative to HL7/FHIR compliance for solving data exchange fragmentation. Kevin Hodak, VP of Strategy and Integration at Concord Technologies, represented the company alongside executives from athenahealth, Oceans Healthcare, and North Shore Community Health, with the panel moderated by Suzanna Hoppszallern, Senior Editor of Data and Research at the American Hospital Association. This is a notable stance for a vendor in a heavily regulated industry, and one that will require substantiation as the company's AI roadmap matures.

Technical specifications

Feature Specification
Core platform Concord Connect
AI technology Practical AI for healthcare documents
Processing volume 4 billion+ pages annually (self-reported)
Network uptime 99.99% (advertised)
Input channels Digital fax, Direct Secure Messaging (DSM), email, SFTP
Healthcare integration EHR systems via API ("last mile" integration)
Data types PHI, patient records, insurance claims, prior authorizations, referrals, revenue cycle documentation
Industry focus Healthcare providers, payers, regulated industries
Customer retention 99% (self-reported)
Net Promoter Score 84 (self-reported)
Founded 1996
EBITDA USD 40-50M (unverified, sourced from Ion Analytics anonymous sources)
Minority investor Excellere Partners (since 2019)
Recent acquisitions Biscom (Jan 2024), Opero (Nov 2024)

Resources

Company information

Headquarters: Seattle, Washington, United States

Founded: 1996

Founder: Chris Moore (Board Chair, retains controlling stake)

CEO: William Cavanaugh

CTO: Chris Larkin

CMO: Julie Freguia

VP, Strategy and Integration: Kevin Hodak

Minority investor: Excellere Partners (Denver), stake acquired 2019

M&A status: Baird appointed as sell-side advisor, February 2026 (Ion Analytics, unverified)